2024 Q2 Form 10-Q Financial Statement

#000095017024091260 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $130.8M
YoY Change 22.81%
Cost Of Revenue $34.45M
YoY Change 6.88%
Gross Profit $96.40M
YoY Change 29.72%
Gross Profit Margin 73.67%
Selling, General & Admin $52.90M
YoY Change 34.78%
% of Gross Profit 54.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $205.0K
YoY Change -27.56%
% of Gross Profit 0.21%
Operating Expenses $125.1M
YoY Change 15.57%
Operating Profit $5.727M
YoY Change -432.97%
Interest Expense $6.714M
YoY Change -8.4%
% of Operating Profit 117.23%
Other Income/Expense, Net $2.381M
YoY Change 89.42%
Pretax Income $1.313M
YoY Change -104.69%
Income Tax -$1.824M
% Of Pretax Income -138.92%
Net Earnings $3.137M
YoY Change -111.32%
Net Earnings / Revenue 2.4%
Basic Earnings Per Share $0.29
Diluted Earnings Per Share $0.26
COMMON SHARES
Basic Shares Outstanding 10.79M
Diluted Shares Outstanding 12.09M

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.36M
YoY Change 1.68%
Cash & Equivalents $98.36M
Short-Term Investments
Other Short-Term Assets $5.241M
YoY Change -16.52%
Inventory
Prepaid Expenses
Receivables $196.8M
Other Receivables $23.04M
Total Short-Term Assets $323.5M
YoY Change 15.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.961M
YoY Change -16.48%
Goodwill
YoY Change
Intangibles $168.3M
YoY Change -9.15%
Long-Term Investments
YoY Change
Other Assets $52.49M
YoY Change 4.36%
Total Long-Term Assets $222.3M
YoY Change -6.24%
TOTAL ASSETS
Total Short-Term Assets $323.5M
Total Long-Term Assets $222.3M
Total Assets $545.7M
YoY Change 5.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.98M
YoY Change 14.42%
Accrued Expenses $14.70M
YoY Change 73.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.68M
YoY Change 24.2%
LONG-TERM LIABILITIES
Long-Term Debt $194.4M
YoY Change -4.72%
Other Long-Term Liabilities $23.08M
YoY Change 35.01%
Total Long-Term Liabilities $23.08M
YoY Change 35.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.68M
Total Long-Term Liabilities $23.08M
Total Liabilities $267.3M
YoY Change 1.14%
SHAREHOLDERS EQUITY
Retained Earnings -$692.5M
YoY Change -0.27%
Common Stock $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.700M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $278.5M
YoY Change
Total Liabilities & Shareholders Equity $545.7M
YoY Change 5.37%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income $3.137M
YoY Change -111.32%
Depreciation, Depletion And Amortization $205.0K
YoY Change -27.56%
Cash From Operating Activities $47.80M
YoY Change 35.16%
INVESTING ACTIVITIES
Capital Expenditures $2.244M
YoY Change 37.0%
Acquisitions
YoY Change
Other Investing Activities -$41.68M
YoY Change 22.75%
Cash From Investing Activities -$43.92M
YoY Change 23.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.670M
YoY Change -68.05%
NET CHANGE
Cash From Operating Activities 47.80M
Cash From Investing Activities -43.92M
Cash From Financing Activities -2.670M
Net Change In Cash 1.208M
YoY Change -114.08%
FREE CASH FLOW
Cash From Operating Activities $47.80M
Capital Expenditures $2.244M
Free Cash Flow $45.55M
YoY Change 35.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001807846
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2024Q2 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2024Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39346
dei Entity Registrant Name
EntityRegistrantName
MoneyLion Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0849243
dei Entity Address Address Line1
EntityAddressAddressLine1
249-245 West 17th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10011
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
300-9865
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98361000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92195000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1585000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
128000
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
4749000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
2284000
CY2024Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
237358000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
208167000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40523000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35329000
CY2024Q2 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
150174000
CY2023Q4 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
131283000
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
196835000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
172838000
CY2024Q2 ml Enterprise Receivables
EnterpriseReceivables
23045000
CY2023Q4 ml Enterprise Receivables
EnterpriseReceivables
15978000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1961000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1864000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168302000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
176541000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52490000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53559000
CY2024Q2 us-gaap Assets
Assets
545743000
CY2023Q4 us-gaap Assets
Assets
515259000
CY2024Q2 ml Secured Loans
SecuredLoans
64482000
CY2023Q4 ml Secured Loans
SecuredLoans
64334000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
48984000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
52396000
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
810000
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
810000
CY2024Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
129932000
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
125419000
CY2024Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
129932000
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
125419000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23079000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15077000
CY2024Q2 us-gaap Liabilities
Liabilities
267287000
CY2023Q4 us-gaap Liabilities
Liabilities
258036000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
980662000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
969641000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-692507000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-702719000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32333
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32333
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
278456000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
257223000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
545743000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
515259000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
127890000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
103237000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
245963000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
193978000
CY2024Q2 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
2956000
CY2023Q2 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
3304000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
5889000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
6232000
CY2024Q2 us-gaap Revenues
Revenues
130846000
CY2023Q2 us-gaap Revenues
Revenues
106541000
us-gaap Revenues
Revenues
251852000
us-gaap Revenues
Revenues
200210000
CY2024Q2 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
33431000
CY2023Q2 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
25562000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
53661000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
42073000
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
24852000
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
22572000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
49638000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
46980000
CY2024Q2 us-gaap Marketing Expense
MarketingExpense
10530000
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
6549000
us-gaap Marketing Expense
MarketingExpense
21396000
us-gaap Marketing Expense
MarketingExpense
12941000
CY2024Q2 ml Direct Operating Cost
DirectOperatingCost
34449000
CY2023Q2 ml Direct Operating Cost
DirectOperatingCost
32230000
ml Direct Operating Cost
DirectOperatingCost
65838000
ml Direct Operating Cost
DirectOperatingCost
62032000
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
11007000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
4518000
us-gaap Professional Fees
ProfessionalFees
16773000
us-gaap Professional Fees
ProfessionalFees
9517000
CY2024Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6512000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5611000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13098000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11649000
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-4338000
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-11219000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-14658000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20214000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
125119000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
108261000
us-gaap Operating Expenses
OperatingExpenses
235062000
us-gaap Operating Expenses
OperatingExpenses
205406000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5727000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1720000
us-gaap Operating Income Loss
OperatingIncomeLoss
16790000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5196000
CY2024Q2 us-gaap Interest Expense
InterestExpense
6714000
CY2023Q2 us-gaap Interest Expense
InterestExpense
7330000
us-gaap Interest Expense
InterestExpense
13531000
us-gaap Interest Expense
InterestExpense
14841000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
81000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-162000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
CY2023Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6367000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2381000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1257000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4740000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2906000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1313000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27985000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7999000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37226000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1824000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-262000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2213000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-286000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
3137000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
us-gaap Profit Loss
ProfitLoss
10212000
us-gaap Profit Loss
ProfitLoss
-36940000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3137000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25056000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10212000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36250000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10862853
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9234238
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10694635
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8944836
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12091421
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9234238
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11954975
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8944836
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
270458000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7531000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2670000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
3137000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
278456000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257223000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14028000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-3007000
us-gaap Net Income Loss
NetIncomeLoss
10212000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
278456000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95491000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5250000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-183000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
45000
CY2023Q2 ml Reversal Of Previously Accrued Dividends On Preferred Stock
ReversalOfPreviouslyAccruedDividendsOnPreferredStock
2667000
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2976000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
174849000
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-11000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-27723000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
253665000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99161000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10955000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-782000
ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
1914000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
45000
ml Reversal Of Previously Accrued Dividends On Preferred Stock
ReversalOfPreviouslyAccruedDividendsOnPreferredStock
690000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2976000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
174849000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
493000
us-gaap Net Income Loss
NetIncomeLoss
-36940000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
253665000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
3137000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
us-gaap Profit Loss
ProfitLoss
10212000
us-gaap Profit Loss
ProfitLoss
-36940000
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33431000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25562000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53661000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42073000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6331000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6113000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12543000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12297000
CY2024Q2 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-322000
CY2023Q2 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-782000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-678000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-1398000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
81000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-162000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
CY2023Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6367000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-44000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
171000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
53000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
178000
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7531000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5250000
us-gaap Share Based Compensation
ShareBasedCompensation
14028000
us-gaap Share Based Compensation
ShareBasedCompensation
10955000
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
235000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-400000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
471000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-493000
CY2024Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
38000
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
211000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
76000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
238000
CY2024Q2 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
5527000
CY2023Q2 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
-1708000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
7067000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
2422000
CY2024Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3117000
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5610000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1753000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4360000
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1103000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1156000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3359000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8649000
CY2024Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
237000
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2505000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1354000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4215000
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47798000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35363000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81437000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38043000
CY2024Q2 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
41676000
CY2023Q2 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
33185000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
69398000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
52832000
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2244000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1638000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4401000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2675000
CY2023Q2 ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-766000
ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-1116000
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43920000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35589000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73799000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56623000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
4000000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-24000000
CY2023Q2 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5000000
CY2023Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
154000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
154000
CY2023Q2 ml Payments For Automatic Conversion Of Redeemable Convertible Preferred Stock
PaymentsForAutomaticConversionOfRedeemableConvertiblePreferredStock
-3007000
ml Payments For Automatic Conversion Of Redeemable Convertible Preferred Stock
PaymentsForAutomaticConversionOfRedeemableConvertiblePreferredStock
-3007000
CY2024Q2 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-2670000
CY2023Q2 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-183000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-3007000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-782000
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2670000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8356000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
993000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32955000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1208000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8582000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8631000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51535000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101902000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110756000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94479000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153709000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103110000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103110000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
6400000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
7043000
us-gaap Interest Paid Net
InterestPaidNet
12848000
us-gaap Interest Paid Net
InterestPaidNet
14508000
CY2023Q2 ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
45000
ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
45000
CY2023Q2 ml Automatic Conversion Of Redeemable Convertible Preferred Stock To Common Stock
AutomaticConversionOfRedeemableConvertiblePreferredStockToCommonStock
174849000
ml Automatic Conversion Of Redeemable Convertible Preferred Stock To Common Stock
AutomaticConversionOfRedeemableConvertiblePreferredStockToCommonStock
174849000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
CY2023Q2 ml Issuance Of Common Stock To Settle Accrued Dividends On Preferred Stock And Preferred Stock Equivalents
IssuanceOfCommonStockToSettleAccruedDividendsOnPreferredStockAndPreferredStockEquivalents
3280000
ml Issuance Of Common Stock To Settle Accrued Dividends On Preferred Stock And Preferred Stock Equivalents
IssuanceOfCommonStockToSettleAccruedDividendsOnPreferredStockAndPreferredStockEquivalents
3280000
CY2023Q2 ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
1744000
ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
1864000
CY2023Q2 ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
1000
ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
1914000
CY2023Q2 ml Equity Issued As Settlement Of Contingent Consideration Related To Engine Acquisition
EquityIssuedAsSettlementOfContingentConsiderationRelatedToEngineAcquisition
1440000
ml Equity Issued As Settlement Of Contingent Consideration Related To Engine Acquisition
EquityIssuedAsSettlementOfContingentConsiderationRelatedToEngineAcquisition
1440000
ml Lease Liabilities Incurred In Exchange For Operating Rightofuse Assets
LeaseLiabilitiesIncurredInExchangeForOperatingRightofuseAssets
8885000
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-30
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the effective time of the Reverse Stock Split, every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock, and the total number of shares of Class A Common Stock authorized for issuance was reduced by a corresponding proportion from 2,000,000,000 shares to 66,666,666 shares
us-gaap Conversion Of Stock Type Of Stock Converted
ConversionOfStockTypeOfStockConverted
every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock
CY2024Q2 ml Service And Subscription Fees
ServiceAndSubscriptionFees
89444000
CY2023Q2 ml Service And Subscription Fees
ServiceAndSubscriptionFees
66268000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
174653000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
128706000
CY2024Q2 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
2956000
CY2023Q2 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
3304000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
5889000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
6232000
CY2024Q2 ml Total Consumer Revenues
TotalConsumerRevenues
92400000
CY2023Q2 ml Total Consumer Revenues
TotalConsumerRevenues
69572000
ml Total Consumer Revenues
TotalConsumerRevenues
180542000
ml Total Consumer Revenues
TotalConsumerRevenues
134938000
CY2024Q2 ml Enterprise Service Revenues
EnterpriseServiceRevenues
38446000
CY2023Q2 ml Enterprise Service Revenues
EnterpriseServiceRevenues
36969000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
71310000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
65272000
CY2024Q2 us-gaap Revenues
Revenues
130846000
CY2023Q2 us-gaap Revenues
Revenues
106541000
us-gaap Revenues
Revenues
251852000
us-gaap Revenues
Revenues
200210000
CY2024Q2 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2023Q2 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2024Q2 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2023Q4 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2024Q2 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
272000
CY2023Q2 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
366000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
509000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
673000
CY2024Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
75085000
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
66815000
CY2024Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
139992000
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
120336000
CY2024Q2 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
215077000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
187151000
CY2024Q2 ml Fees Receivables
FeesReceivables
16664000
CY2023Q4 ml Fees Receivables
FeesReceivables
16137000
CY2024Q2 ml Subscription Receivables
SubscriptionReceivables
4170000
CY2023Q4 ml Subscription Receivables
SubscriptionReceivables
3491000
CY2024Q2 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
69000
CY2023Q4 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
86000
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
1378000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1302000
CY2024Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
237358000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
208167000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4904000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4844000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2943000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2980000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1961000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1864000
CY2024Q2 us-gaap Depreciation
Depreciation
205000
CY2023Q2 us-gaap Depreciation
Depreciation
283000
us-gaap Depreciation
Depreciation
391000
us-gaap Depreciation
Depreciation
587000
CY2024Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
46969000
CY2023Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
43105000
CY2024Q2 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1706000
CY2023Q4 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1695000
CY2024Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2023Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2024Q2 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
15960000
CY2023Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
15960000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56833000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44719000
CY2024Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
168302000
CY2023Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
176541000
CY2024Q2 ml Internal Use Software Cost Capitalized
InternalUseSoftwareCostCapitalized
2052000
CY2023Q2 ml Internal Use Software Cost Capitalized
InternalUseSoftwareCostCapitalized
1689000
ml Internal Use Software Cost Capitalized
InternalUseSoftwareCostCapitalized
3912000
ml Internal Use Software Cost Capitalized
InternalUseSoftwareCostCapitalized
2851000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6126000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5830000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12152000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11710000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
12318000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24636000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24636000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24064000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21755000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
59187000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
166596000
CY2024Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
29502000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
37362000
CY2024Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
5241000
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
5987000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13521000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6159000
CY2024Q2 ml Others Accrued Assets
OthersAccruedAssets
4226000
CY2023Q4 ml Others Accrued Assets
OthersAccruedAssets
4051000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52490000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53559000
CY2024Q2 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
518000
CY2023Q4 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
666000
CY2024Q2 us-gaap Secured Debt
SecuredDebt
64482000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
64334000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1068000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1581000
CY2024Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
129932000
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
125419000
us-gaap Debt Instrument Description
DebtInstrumentDescription
The interest rate as of June 30, 2024 on the Term A-1 Loans was 12.33%.
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1283000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
785000
us-gaap Operating Lease Cost
OperatingLeaseCost
2387000
us-gaap Operating Lease Cost
OperatingLeaseCost
1581000
CY2024Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
166000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
332000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2295000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4706000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3486000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3334000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3271000
CY2024Q2 ml Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2939000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20031000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5333000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14698000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.133
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.277
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.008
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Shares of Series A Preferred Stock were convertible into shares of Class A Common Stock on a one-for-thirty basis, subject to customary anti-dilution adjustments.
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7531000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5250000
us-gaap Share Based Compensation
ShareBasedCompensation
14028000
us-gaap Share Based Compensation
ShareBasedCompensation
10955000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
3137000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
us-gaap Profit Loss
ProfitLoss
10212000
us-gaap Profit Loss
ProfitLoss
-36940000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3137000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25056000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10212000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36250000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10862853
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9234238
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10694635
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8944836
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1228568
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1260340
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12091421
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9234238
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11954975
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8944836
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1690695
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3885324
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1738251
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3885324
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
-180000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
true
CY2024Q2 ecd Trd Arr Adoption Date
TrdArrAdoptionDate
May 24, 2024

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-091260-index-headers.html Edgar Link pending
0000950170-24-091260-index.html Edgar Link pending
0000950170-24-091260.txt Edgar Link pending
0000950170-24-091260-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ml-20240630.htm Edgar Link pending
ml-20240630.xsd Edgar Link pending
ml-ex10_1.htm Edgar Link pending
ml-ex10_2.htm Edgar Link pending
ml-ex10_3.htm Edgar Link pending
ml-ex31_1.htm Edgar Link pending
ml-ex31_2.htm Edgar Link pending
ml-ex32_1.htm Edgar Link pending
ml-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ml-20240630_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending